Ovid Therapeutics (OVID) Interest & Investment Income (2018 - 2020)
Ovid Therapeutics (OVID) posted Interest & Investment Income of -$65704.0 for Q2 2020, down 203.9% on a QoQ basis from $63235.0 in Q1 2020, and down 4766.96% year-over-year from $1407.9 in Q3 2019.
Ovid Therapeutics (OVID) Interest & Investment Income (2018 - 2020) Analysis & Trends
Ovid Therapeutics' Interest & Investment Income history runs 3 years deep, the most recent figure standing at -$65704.0 for Q2 2020.
- Quarterly Interest & Investment Income fell 4766.96% year-over-year to -$65704.0 in Q2 2020, while the trailing twelve-month figure through Mar 2020 was $64354.0 (up 72.7% YoY) and the FY2019 annual result came in at $4298.0, up 334.99% from the prior year.
- Interest & Investment Income was -$65704.0 for Q2 2020 at Ovid Therapeutics, down from $63235.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $63235.0 in Q1 2020 and bottomed at -$65704.0 in Q2 2020.
- A 3-year average of $0.0 and a median of $2846.0 in 2018 frame the typical range for Interest & Investment Income.
- Peak annual rise in Interest & Investment Income reached 1889.15% in 2020, while the deepest fall reached 4766.96% in 2020.
- Ovid Therapeutics' Interest & Investment Income stood at $2846.0 in 2018, then fell by 13.25% to $2469.0 in 2019, then tumbled by 2761.16% to -$65704.0 in 2020.
- Business Quant data shows OVID's Interest & Investment Income at -$65704.0 in Q2 2020, $63235.0 in Q1 2020, and $2469.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Ovid Therapeutics | 118.66 Mn | -36.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -65,704.00 |
| Mar 31, 2020 | 63,235.00 |
| Dec 31, 2019 | 2,469.00 |
| Jun 30, 2019 | -1,350.00 |
| Mar 31, 2019 | 3,179.00 |
| Dec 31, 2018 | 2,846.00 |
| Sep 30, 2018 | 11,347.00 |
| Jun 30, 2018 | 19,892.00 |
| Mar 31, 2018 | -35,914.00 |